Skip to main content
. 2017 Dec;6(6):689–707. doi: 10.21037/tlcr.2017.09.02

Table 2. Challenges for the implementation of MR-guided lung radiotherapy.

Challenge Stage of pathway affected Effect Source Potential solution
Low MRI signal in lungs Staging and delineation Reduced conspicuity Low proton density in lung parenchyma Hyper-polarised gas imaging, lower field strength (to increase relaxation times), or ultra-short echo time (UTE) sequences (less affected by fast T2 decay in lung parenchyma)
Motion during image acquisition Staging and delineation Motion artifacts Physiological motion (respiratory/cardiac) Acquisition with triggering or breath hold. Signal averaging, motion robust readouts
Poor visualisation of small airways on MR imaging Delineation and planning Potential hotspots (secondary to Lorentz force) that are not accounted for Bronchi are not well visualized due to short T2 Further development of ultra-short echo time sequences
Susceptibility induced field inhomogeneities Planning Reduced geometric fidelity Susceptibility differences at Air-Tissue interfaces Higher bandwidth, distortion corrections using B0 field maps, lower field strength
Synthetic CT generation difficult in thorax Planning Inaccurate results with current methods Short T2 of Lung tissue challenges current segmentation and contrast based approaches Continued research using specialised acquisition methods (e.g., ultrashort echo time) (29)
Lateral patient re-positioning limited Patient setup Less freedom in patient positioning Machine geometry Online re-planning to adapt to daily situation
Electron-return effect (Lorentz force) Planning Possible hotspots at air-tissue interface Altered path of secondary electrons when B>0 Accounted for within planning (30,31)
Motion during setup phase Verification ‘Snapshot’ representation of setup image Physiological motion Align treatment position with setup position e.g., exhale imaging and gating. Or 4D-MRI acquisition with possibility for mid-position reconstruction (32-34)
Motion during treatment phase (treatment delivery) ‘Intrafraction motion leads to dose ‘blurring’ necessitating increased RT planning margins’ Physiological motion Treatment on Mid-position, or implementation of gating/tracking
Motion during treatment phase (real-time imaging) Required temporal resolution too high for full volumetric cine imaging Physiological motion, inherent (lack of) speed in MRI acquisition Model based approaches that map volumetric information onto fast 2D acquisitions (35)